COMPARISON STUY OF KINESIOTAPE AND LOW-LEVEL LASER THERAPY ON HYPERTROPHIC SCAR
NCT ID: NCT07209891
Last Updated: 2025-10-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2023-10-05
2024-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pulsed High Intensity Laser Versus Extracorporeal Shockwave Therapy on Hypertrophic Scar Post Burn
NCT06803472
Effect of Nd-YAG Laser on Hypertrophic Scar
NCT06347081
Effects of Pulsed Dye and CO2 Laser in Treatment of Hypertrophic Burn Scars.
NCT04769089
Effect of Laser Puncture on Liver Enzymes Post Burn
NCT05728450
Effect of Elastic Bandage With Tension on the Inflammatory Response of Hypertrophic Scars
NCT04643223
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Design: Single-center, three-arm, parallel randomized controlled trial (1:1:1); assessor- and analyst-blinded.
Setting: Outpatient clinic, Faculty of Physical Therapy, Cairo University (Giza, Egypt).
Participants: \~60 patients with clinically diagnosed hypertrophic scars after burns; able to complete 8-week treatment; standard exclusions for open wounds, infection, photosensitivity, etc.
Interventions:
Arm A: KT + standardized scar care (tape reapplied every 2-3 days).
Arm B: LLLT (905-nm pulsed device; \~16.2 J/cm²; 3×/week).
Arm C: KT + LLLT on the same schedule.
Duration: 8-week treatment; optional week-12 follow-up for durability.
Primary Outcome: Change in scar pliability/firmness (modified Schiotz tonometer) from baseline to week 8.
Secondary Outcomes: Change in pain (10-cm VAS); treatment-related adverse events; optional week-12 persistence.
Randomization/Concealment: Computer-generated sequence; SNOSE envelopes.
Analysis: Intention-to-treat; linear mixed-effects models with adjusted pairwise contrasts (Holm/Bonferroni).
Sponsor: Cairo University. Collaborators: National Institute of Laser Enhanced Sciences (NILES) and Faculty of Physical Therapy, Cairo University.
Hypothesis: KT+LLLT will yield greater improvements than either modality alone.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
kinesio tape
Kinesiotape was used to cover the full extent of the scar tissue
Kinesio Tape
Cotton elastic tape applied along the full length/width of the target hypertrophic scar with \~25-50% stretch while the scar is on gentle lengthening. Continuous wear; replaced every 2-3 days.
Standardized Scar Care (concomitant for all arms)
Uniform background care applied across all groups; recorded in CRFs; prohibited co-interventions (e.g., intralesional steroids, microneedling, ablative lasers, new pressure garments during the study).
low-level laser
Giotto MED SPA-Italy-Ga-As low-level laser with the following parameters: wavelength 905 nm, energy density 16.2 J/cm2, pulsed mode with frequency 3000 Hz, and max output power 30 W. The application technique was a circular cluster probe with three output beams that each produced 30 W of power. The length of therapy varies according on the size of the scar.
Low-Level Laser Therapy (LLLT), 905-nm pulsed Ga-As
Fluence 16.2 J/cm² at skin; pulse frequency 3000 Hz; session duration \~15 min at standardized distance (\~10 cm) using an orange medical filter; protective eyewear for patient and staff.
Standardized Scar Care (concomitant for all arms)
Uniform background care applied across all groups; recorded in CRFs; prohibited co-interventions (e.g., intralesional steroids, microneedling, ablative lasers, new pressure garments during the study).
kinesio tape and lowlevel laser
combined treatment of low-level laser and kinesio tape
Kinesio Tape
Cotton elastic tape applied along the full length/width of the target hypertrophic scar with \~25-50% stretch while the scar is on gentle lengthening. Continuous wear; replaced every 2-3 days.
Low-Level Laser Therapy (LLLT), 905-nm pulsed Ga-As
Fluence 16.2 J/cm² at skin; pulse frequency 3000 Hz; session duration \~15 min at standardized distance (\~10 cm) using an orange medical filter; protective eyewear for patient and staff.
Standardized Scar Care (concomitant for all arms)
Uniform background care applied across all groups; recorded in CRFs; prohibited co-interventions (e.g., intralesional steroids, microneedling, ablative lasers, new pressure garments during the study).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Kinesio Tape
Cotton elastic tape applied along the full length/width of the target hypertrophic scar with \~25-50% stretch while the scar is on gentle lengthening. Continuous wear; replaced every 2-3 days.
Low-Level Laser Therapy (LLLT), 905-nm pulsed Ga-As
Fluence 16.2 J/cm² at skin; pulse frequency 3000 Hz; session duration \~15 min at standardized distance (\~10 cm) using an orange medical filter; protective eyewear for patient and staff.
Standardized Scar Care (concomitant for all arms)
Uniform background care applied across all groups; recorded in CRFs; prohibited co-interventions (e.g., intralesional steroids, microneedling, ablative lasers, new pressure garments during the study).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
20 Years
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Huda Badr Abd El Hamed
lecturer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Huda Badr Abd Elhamed
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
National institute of laser
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.